As of 2025-07-09, the EV/EBITDA ratio of Angion Biomedica Corp (ANGN) is -0.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANGN's latest enterprise value is 8.43 mil USD. ANGN's TTM EBITDA according to its financial statements is -30.16 mil USD. Dividing these 2 quantities gives us the above ANGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 9.4x | 8.2x |
| Forward P/E multiples | 8.2x - 14.4x | 10.9x |
| Fair Price | (7.47) - (8.68) | (8.85) |
| Upside | -847.3% - -967.5% | -984.6% |
| Date | EV/EBITDA |